Similar to miR-34a, miR-141 was underexpressed in CD44+ prostate CSCs, inhibited tumor regeneration when expressed in prostate cancer cell lines, and regulated CD44 through a putative miR-141 binding site in the 3’UTR of CD44 (Liu et al., 2017). The gene discussed is CD44; the disease is neoplasm.